Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09ODU
|
|||
| Former ID |
DPR000188
|
|||
| Drug Name |
XL475
|
|||
| Indication | Type-2 diabetes [ICD-11: 5A11; ICD-9: 250] | Preclinical | [1] | |
| Company |
Exelixis
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | G-protein coupled bile acid receptor 1 (GPBAR1) | Target Info | Agonist | [1] |
| Reactome | Class A/1 (Rhodopsin-like receptors) | |||
| G alpha (s) signalling events | ||||
| WikiPathways | GPCR ligand binding | |||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Exelixis (2011). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.